摘要
This project was supported by the National Natural Science Foundation of China (No. 39670325). Objective To compare the effect of ouabain on the blood pressure of rats with that of digoxin to find the evidences of the relationship between endogenous ouabain (EO) and development of hypertension. Methods Sprague Dawley rats, which were divided into 3 groups, were infused with ouabain (23.75 μg·kg 1 /day, i.p.), digoxin (36.84 μg·kg 1 /day, i.p.) and normal saline (NS) once a day respectively. Systolic blood pressure and body weight were recorded weekly. Five weeks later, rats of ouabain group were randomly assigned to three infusion subgroups: Oc group, continued with ouabain infusion; Od group, added digoxin (73.68 μg·kg 1 /day, i.p.); and Os group, stopped administration of ouabain. Another week later, direct blood pressure was recorded in aorta. Systolic and diastolic cardiac function, plasma renin activity and aldosterone levels of all the rats were measured. Results After a latent period of one week, blood pressure of Ouabain group increased significantly [95.4±11.8 mmHg (1 mmHg=0.133 kPa) at the beginning of the experiment vs 122.5 ±16.9 mmHg at the end of week 6, P<0.05] with normal plasma renin activity and higher aldosterone (1.28±0.45 ng/ml vs 0.69±0.27 ng/ml, P<0.05). The blood pressure decreased after either withdrawal of ouabain or addition of digoxin (116.3±14.4 mmHg vs 100±10.7 mmHg, P<0.05; 123.9±13.9 vs 103.3±10.5 mmHg, P<0.05, respectively). No difference of blood pressure was found between the digoxin and NS group. Conclusions Our results suggested that EO might be one of the causes of the development of hypertension. Aldosterone might play some role in the mechanism of ouabain induced hypertension. Digoxin can not induce hypertension. There is a great difference between the effect of ouabain and digoxin on the blood pressure. Moreover, digoxin can reverse the hypertension induced by ouabain.
This project was supported by the National Natural Science Foundation of China (No. 39670325). Objective To compare the effect of ouabain on the blood pressure of rats with that of digoxin to find the evidences of the relationship between endogenous ouabain (EO) and development of hypertension. Methods Sprague Dawley rats, which were divided into 3 groups, were infused with ouabain (23.75 μg·kg 1 /day, i.p.), digoxin (36.84 μg·kg 1 /day, i.p.) and normal saline (NS) once a day respectively. Systolic blood pressure and body weight were recorded weekly. Five weeks later, rats of ouabain group were randomly assigned to three infusion subgroups: Oc group, continued with ouabain infusion; Od group, added digoxin (73.68 μg·kg 1 /day, i.p.); and Os group, stopped administration of ouabain. Another week later, direct blood pressure was recorded in aorta. Systolic and diastolic cardiac function, plasma renin activity and aldosterone levels of all the rats were measured. Results After a latent period of one week, blood pressure of Ouabain group increased significantly [95.4±11.8 mmHg (1 mmHg=0.133 kPa) at the beginning of the experiment vs 122.5 ±16.9 mmHg at the end of week 6, P<0.05] with normal plasma renin activity and higher aldosterone (1.28±0.45 ng/ml vs 0.69±0.27 ng/ml, P<0.05). The blood pressure decreased after either withdrawal of ouabain or addition of digoxin (116.3±14.4 mmHg vs 100±10.7 mmHg, P<0.05; 123.9±13.9 vs 103.3±10.5 mmHg, P<0.05, respectively). No difference of blood pressure was found between the digoxin and NS group. Conclusions Our results suggested that EO might be one of the causes of the development of hypertension. Aldosterone might play some role in the mechanism of ouabain induced hypertension. Digoxin can not induce hypertension. There is a great difference between the effect of ouabain and digoxin on the blood pressure. Moreover, digoxin can reverse the hypertension induced by ouabain.
